Fig A4.
Monitoring of disease clearance during remission induction therapy in peripheral blood. (A) Patients (n = 11) with slow clearance of T-cell lymphoblastic lymphoma (T-LL) cells. (B) Patients (n = 19) with rapid clearance of T-LL cells.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.